Skip to main content
SpringerLink
Log in

Neuromuscular transmission disorders and other conditions

  • Chapter
Atlas of Neuromuscular Diseases

  • 1498 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 289.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • AAEM Quality Assurance Committee (2001) Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert Eaton myasthenic syndrome. Muscle Nerve 24: 1239–1247

    Google Scholar 

  • Bromberg MB (2001) Myasthenia gravis and myasthenic syndromes. In: Younger DS (ed) Motor disorders. Williams & Wilkins, Lippincott, Philadelphia, pp 163–178

    Google Scholar 

  • Evoli A, Minisci C, Di Schino C, et al (2002) Thymoma in patients with MG. Neurology 59: 1844–1850

    CAS  PubMed  Google Scholar 

  • Grob D, Arsuie EL, Brunner NG, et al (1987) The course of myasthesia and therapies affecting outcome. Ann NY Acad Sci 505: 472–499

    CAS  PubMed  Google Scholar 

  • Mantegazza R, Beghi E, Pareyson D, et al (1990) A multicenter follow up study of 1152 patients with myasthenia gravis in Italy. J Neurol 237: 339–344

    Article  CAS  PubMed  Google Scholar 

  • Osserman KE (1958) Myasthenia gravis. Grune & Stratton, New York

    Google Scholar 

  • Poulas K, Tsibri E, Kokla A, et al (2001) Epidemiology of seropositive myasthenia gravis in Greece. J Neurol Neurosurg Psychiatry 71: 352–356

    Article  CAS  PubMed  Google Scholar 

  • Wolfe GI, Bahron RJ, Fester BM, et al (2002) Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis. Muscle Nerve 26: 549–552

    Article  CAS  PubMed  Google Scholar 

  • Argov Z, Mastaglia FL (1979) Disorders of neuromuscular transmission caused by drugs. N Engl J Med 301: 409–413

    CAS  PubMed  Google Scholar 

  • Barrons RW (1997) Drug-induced neuromuscular blockade and myasthenia gravis. Pharmacotherapy 17: 1220–1232

    CAS  PubMed  Google Scholar 

  • Howard HF (2002) Neurotoxicology of neuromuscular transmission. In:Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro B (eds) Neuromuscular disorders in clinical practice. Butterworth and Heinemann, Boston, pp 964–986

    Google Scholar 

  • Senanayake N, Roman GC (1992) Disorders of neuromuscular transmission due to natural environmental toxins. J Neurol Sci 107: 1–13

    Article  CAS  PubMed  Google Scholar 

  • Wittbrodt WT (1997) Drugs and myasthenia gravis. An update. Arch Intern Med 157: 499–408

    Article  Google Scholar 

  • Mason WP, Graus F, Lang B, et al (1997) Small cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert Eaton myasthenic syndrome. Brain 120: 1279–1300

    Article  PubMed  Google Scholar 

  • Nakao YK, Motomura M, Fukudome T et al (2002) Seronegative Lambert Eaton myasthenic syndrome. Neurology 59: 1773–1775

    CAS  PubMed  Google Scholar 

  • Oh SJ (1989) Diverse electrophysiological spectrum of the Lambert Eaton myasthenic syndrome. Muscle Nerve 12: 464–469

    CAS  PubMed  Google Scholar 

  • O’Neill JH, Murray NMF, Newsom-Davies J (1988) The Lambert Eaton myasthenic syndrome. Brain 111: 577–596

    PubMed  Google Scholar 

  • O’suilleabhain P, Low PA, Lennon VA (1998) Autonomic dysfunction in the Lambert-Eaton myasthenic syndrome. Neurology 50: 88–93

    CAS  PubMed  Google Scholar 

  • Cherington M (1998) Clinical spectrum of botulism. Muscle Nerve 21: 701-10

    Article  PubMed  Google Scholar 

  • Cherington M (2002) Botulism. In: Katirji B, Kaminski HJ, Preston DC, Ruff RL, Shapiro B (eds) Neuromuscular disorders in clinical practice. Butterworth Heinemann, Boston, pp 942–952

    Google Scholar 

  • Hiersemenzel LP, Jerman M, Waespe W (2000) Deszendierende Lähmung durch Wundbotulismus. Eine Falldarstellung. Nervenarzt 71: 130–133

    CAS  Google Scholar 

  • Maselli RA, Bakshi N (2000) Botulism. Muscle Nerve 23: 1137–1144

    Article  CAS  PubMed  Google Scholar 

  • Bleck TP, Brauner JS (1997) Tetanus. In: Scheld WM, Whitley RJ, Durack DT (eds) Infections of the central nervous system, 2nd edn. Raven, Philadelphia, pp 629–653

    Google Scholar 

  • Farrar JJ, et al (2000) Tetanus. J Neurol Neurosurg Psychiatry 69: 292–301

    Article  CAS  PubMed  Google Scholar 

  • Fauveau V, Mamdani M, Steinglass R, et al (1993) Maternal tetanus: magnitude, epidemiology and potential control measures. Int J Gynaecol Obstet 40: 3–12

    Article  CAS  PubMed  Google Scholar 

  • Mastaglia FL (2001) Cervicocranial tetanus presenting with dysphagia: diagnostic value of electrophysiological studies. J Neurol 248: 903–904

    Article  CAS  PubMed  Google Scholar 

  • Orwitz JI, Galetta SL, Teener JW (1997) Bilateral trochlear nerve palsy and downbeat nystagmus in a patient with cephalic tetanus. Neurology 49: 894–895

    CAS  PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag/Wien

About this chapter

Cite this chapter

(2005). Neuromuscular transmission disorders and other conditions. In: Atlas of Neuromuscular Diseases. Springer, Vienna. https://doi.org/10.1007/3-211-26802-2_11

Download citation

  • DOI: https://doi.org/10.1007/3-211-26802-2_11

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83819-8

  • Online ISBN: 978-3-211-26802-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation